Please assess the completion status of the following clinical trial:

Trial Title: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* History of simple or complex partial epilepsy that has been documented or witnessed~* an electroencephalogram (EEG) during the preceding 5 years that has a pattern consistent with the diagnosis of partial epilepsy~* during an 8-week baseline phase, patient must have at least 8 partial seizures while maintaining therapeutic levels of antiepileptic drugs (AEDs) and have no more than one seizure-free interval of up to 3 weeks~* and no seizure-free interval longer than 3 weeks~* good physical health.~Exclusion Criteria:~* Patients having solely generalized seizures or lacking documentation of partial epilepsy~* patients with generalized tonic-clonic seizures or other generalized epilepsies in the absence of an EEG consistent with partial epilepsy~* generalized seizures, which are defined by the EEG wave pattern~* seizures that lack an abnormal pulsation pattern on EEG~* females who are pregnant, nursing, or those not using adequate birth control if capable of having children

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).